Nigeria has taken a major step in the fight against HIV/AIDS with the arrival of its first shipment of Lenacapavir, a groundbreaking long-acting HIV prevention drug.
The National AIDS, Viral Hepatitis and STIs Control Programme (NASCP) under the Federal Ministry of Health and Social Welfare confirmed that the drug arrived on March 10, with support from The Global Fund.
Lenacapavir will be used as Pre-Exposure Prophylaxis (PrEP) for people at risk of HIV infection. Unlike traditional daily prevention pills, this long-acting injectable offers a more convenient option, potentially improving adherence and strengthening Nigeria’s national strategy to reduce new HIV infections.
Health experts say the introduction of Lenacapavir could play a critical role in expanding HIV prevention efforts and protecting vulnerable populations across the country.
Source: TVC NEWS